🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NRG Oncology Membership Reminders: nrgoncology.org/About-Us/Membe…

Interested in SOROCk & still have questions? There are many places to find answers! Follow the QR code on the post to the NRG study page, which includes an FAQ section and the Patient Study Brochure. As always, reach out to NRG and study site personnel with additional questions!

We have recently updated our #NRG2025 agenda with room information for the in-person sessions in Washington, DC. Check it out - nrgoncology.org/Summer2025Mtg/…

July FORTE Fridays! Important Amendment updates, next Coordinator Session & more! ↪️ conta.cc/466BHZY @Fortestudy

We're one week away for our #NRG2025 virtual session - Communications & Digital Engagement (CDE) Workshop. Are you joining us? Details ⬇️ Kristin Higgins Dr. Miriam Knoll The Life Raft Group Sara Rothschild Ryan Strandlund UCLA Health @asco

NRG Oncology Weekly Broadcast for July 14, 2025: conta.cc/3Ufv8wQ

Here's an NRG Podcast NEW EPISODE to go perfectly with that Tuesday morning coffee or tea. We are talking to Ted Hong the PI of NRG-GI003 about protons vs photons for hepatocellular carcinoma: nrgoncology.org/Podcast #LiverTwitter #LiverX #HCC Stephen Chun Lauren Henke, MD, MSCI

The July edition of our NRG Currents newsletter is out! This month's highlights include #BoneCancerAwareness featuring the NRG-CC014 PREEMPT study, recent study activations, PSC column, upcoming podcasts, @FORTEstudy updates & more! ➡️conta.cc/3TD5Fxe

We're changing things up for the #NRG2025 Scientific Session. The "Best of NRG Oncology - Present-o-Rama" with the theme of "Practice Changing Evidence Across the Spectrum of Cancer Care." Join us for this session on Fri/July 25, 3pm! Details ⬇️

Everyone taking part in this study will have some type of surgery to reduce the risk of #ovariancancer, choosing their surgery: removal of the fallopian tubes & remove the ovaries later or the standard of care-removing both the ovaries & fallopian tubes. nrgoncology.org/SOROCk

We recently activated NRG-GI011, also known as LAP100, a Phase III randomized controlled trial will assess the role of dose-escalated radiotherapy (target biologic effective dose of 100 Gy, hence LAP100) in locally advanced pancreatic cancer. ow.ly/zxSe50WqbCT Dr. Nina Niu Sanford

NRG-CC015, a study to examine mindfulness training to improve mental health and well-being in younger breast cancer survivors, also known as “HEAL-ABC” is enrolling young breast cancer survivors who have elevated symptoms associated with depression. ➡️ow.ly/Hz2j50WqF5M

Join our #NRG2025 Investigator Development Roundtable Session. Whether you’re an early career investigator or seasoned member interested in new ways to engage, this session is for you! Preview the table topics in our flyer here: ow.ly/l0PY50Wq2Sh We hope to see you there!

This month's Protocol Support Committee column in the July issue of the NRG Oncology eNewsletter, discusses the roles and key Responsibilities of CRA and CTN Committee Liaisons. Read it here ➡️ow.ly/Gw7O50WqK9a

It's almost time for #NRG2025! Next Friday, July 25th - don't miss our General Session - chaired by our Group Chairs, Drs. Mannel, Wolmark and Quynh Thu Le - to hear updates about NRG Oncology! Details ⬇️

Call for NRG Health Care Access Fellowship Applications! Application submission deadline: September 19, 2025. Read more: nrgoncology.org/HealthCareAcce…

Our patient study webpage for the recently activated HEAL-ABC trial is now available at NRGOncology.org/CC015. Learn more about this study comparing different approaches to delivering mindfulness training in younger breast cancer survivors with elevated symptoms of depression.